PECULIARITIES OF USING THE REVENUE APPROACH FOR EVALUATING INTELLECTUAL PROPERTY OBJECTS IN THE BIOMEDICAL FIELD
DOI:
https://doi.org/10.32471/oncology.2663-7928.t-24-3-2022-g.10795Keywords:
antitumor autovaccine, biomedical industry, immunotherapy, income approach in the assessment of intellectual property rights, intellectual property, license priceAbstract
Effective management of intellectual property (IP) in the form of patents as an intangible assets of a biomedical scientific institution (SI) is one of the main conditions for innovative development. The objective basis and the most important component of management decisions regarding the strategy of commercialization of IP objects is the establishment of their reasonable assessment and determination of the market value. Evaluation of IP market value is particularly relevant, given the lack of a universal, standard method of calculation under terms of purchase and sale through licensing. Purpose: development of a theoretical model for the assessment of IP market value using the income approach in the biomedical industry on the case of the antitumor autovaccine (AAV) manufacturing technology, developed at IEPOR; determination of the price of the license for the transfer of IPR to the technology. Aim: to develop a theoretical model for the assessment of property rights to IP using the income approach in the biomedical industry using the example of AAV technology, determination the price of a license for the transfer of technology rights. Objects and methods: Methodological approaches were used to estimate the value of property rights to IP according to the provisions of Ukrainian National Standards No. 1 and No. 4. Of the three approaches to the assessment of property rights, the income one was chosen, which takes into account the potential income under the conditions of use of IP. The basis of the method is the transfer of the value of IP, determined today, to the future periods of its use. The income approach is the main in conditions of the poorly developed IPO market that exists in the realities of Ukraine. Results: valuation of IP property rights using the income approach in the biomedical industry on the example of AAV technology was carried out using the theoretical calculation model based on the income approach using the cash flow discounting method. The determination of the possible income from the application of the invention, the calculation of the discount rate and the total value of cash flows, as well as the net additional profit from a unit of production (one dose of AAV) were carried out, taking into account the high degree of innovativeness of the AAV manufacturing technology. To construct a discount rate of 18.05%, a model of cumulative construction was used, which involves the assessment of certain factors that generate the risk of not receiving the planned income. The price of the license for the transfer of IP for AAV technology has been determined, taking into account the licensor’s share in the licensee’s profit of 50%, which is UAH 13,038,350. Conclusion: using the example of concrete objects of IP (inventions and utility models), which are the basis of the technology for the production of an AAV developed by IEPOR, a theoretical model for evaluating property rights to IP is presented and the relevance of the application of the income approach in the biomedical industry is demonstrated, which made it possible to reveal the significant commercial potential of the development.
References
Debela DT, Muzazu SG, Heraro KD, et al. New approaches and procedures for cancer treatment. Current perspectives SAGE Open Medicine 2021; 9: 1–10. doi: 10.1177/20503121211034366.
Osipov A, Murphy А, Zheng Lei. From immune checkpoints to vaccines: The past, present and future of cancer immunotherapy. Adv Cancer Res 2019; 143: 63–144. doi.org/10.1016/bs.acr.2019.03.002.
Didenko GV, Krutz OO, Bazas VN, Chekhun VF. Еfficiency of xenogeneic antitumor vaccine in vivo. Oncology 2022; 24 (1): 26–30. doi: 10.32471/oncology.2663-7928.t-24-1-2022-g.10377.
Didenko GV, Lisovenko GS, Krutz OO, et al. Antitumor and antimetastatic efficiency of antitumor vaccine and amixin combined action in mice with Lewis lung carcinoma. Biotechnologia Acta 2016; 9 (3): 76–83. URL: http://nbuv.gov.ua/UJRN/biot_2016_9_3_10.
Tanasienko OA, Cheremshenko NL, Titova GP, et al. Elevation of the efficacy of antitumor vaccine prepared on the base of lectines from В. subtilis В-7025 upon its combined application with probiotics in vivo. Exp Oncol 2005; 27 (4): 336–8.
Potebnya G, Cheremshenko N, Lisovenko G, et al. Аntitumor efficacy of autovaccines prepared from chemoresistant tumor cells with the use of lectin of B. subtilis B-7025. Exp Oncol 2007; 29 (4): 277–80.
Kraśko JA, Žilionytė K, Darinskas A, et al. Bacterial ghosts as adjuvants in syngeneic tumour cell lysate-based anticancer vaccination in a murine lung carcinoma model. Oncol Rep 2017; 37: 171–8. doi: 10.3892/or.2016.5252.
R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of the NAS of Ukraine. Official website https://iepor.org.ua/innovations/anticancer-autovaccinum.html/
Potebnya GP, Tanasienko OA, Titova GP, et al. Specifity and biological activity of cytotoxic lectins synthesized by Bacillus subtilis B-7025. Exp Oncol 2002; 24 (2): 150–2.
Sposib spetsyfichnoi imunoterapii onkolohichnykh khvorykh pislia radykalnoi operatsii: pat. 10555 A Ukraina. Оpubl. 11.10.99. Biul № 6. (in Ukrainian)
Sposib spetsyfichnoi imunoterapii khvorykh kolorektalnym rakom: pat. 47308 A Ukraina. Оpubl. 17.06.2002. Biul № 6. (in Ukrainian)
Sposib imunoterapii autovaktsynoiu khvorykh rakom leheni: pat. 51420 A Ukraina. Оpubl.15.11.2002. Biul № 11. (in Ukrainian)
Sposib kompleksnoho likuvannia raku molochnoi zalozy pry zastosuvanni autovaktsynoterapii: pat. 51187 A Ukraina. Оpubl. 15.11.2002. Biul № 11. (in Ukrainian)
Sposib oderzhannia protypukhlynnoi autovaktsyny: pat. 88842 Ukraina. Оpubl. 25.11.2009. Biul № 22. (in Ukrainian)
Shtam bakterii Bacillus subtilis IBM B-7724 — produtsent tsytotoksychnykh rechovyn z protypukhlynnoiu diieiu: pat. 120572 Ukraina. Оpubl. 26.12.2019. Biul № 24. (in Ukrainian)
Sposib pidvyshchennia protypukhlynnoi efektyvnosti rechovyny z tsytotoksychnoiu diieiu za rakhunok stvorennia liposomalnoi formy: pat. 135896 Ukraina. Оpubl. 25.07.2019. Biul № 14. (in Ukrainian)
Tsytotoksychnyi lektyn z protypukhlynnoiu aktyvnistiu: pat. 141944 Ukraina. Оpubl. 12.05.2020. Biul № 9. (in Ukrainian)
Natsionalnyi standart № 1 «Zahalni zasady otsinky maina i mainovykh prav». Kyiv : Kabinet Ministriv Ukrainy, 2003. Postanova № 1440 vid 10.09.2003 r. (in Ukrainian)
Natsionalnyi standart № 4 «Otsinka mainovykh prav intelektualnoi vlasnosti». Kyiv: Kabinet Ministriv Ukrainy, 2007. Postanova № 1185 vid 03.10.2007 r. (in Ukrainian)
Chuhrii NA. Metodychni pidkhody do otsinky ob`iektiv prava intelektualnoi vlasnosti. Ekonomichni studii 2017; 4 (17): 83–8. (in Ukrainian)
Moroz O, Azarova A, Hoda K. Metody otsiniuvannia obiektiv intelektualnoi vlasnosti. Ekonomichnyi analiz 2012; 10 (2): 422–5. (in Ukrainian)
Tsybulev PN. Otsenka yntellektualnoi sobstvennosty: uch posob. Kyev, 2005. 192. (in Russian)
Khvorost OO. Osoblyvosti otsinky ob’iektiv intelektualnoi vlasnosti v Ukraini. Efektyvna ekonomika 2010; (9): http://www.economy.nayka.com.ua. (in Ukrainian)
Eskondarov MA, Fedotova MA. Otsenka stoimosti bisnesa: uch posob. M., 2016. 348. (in Russian)
National Bank of Ukraine. Official website https://bank.gov.ua/
Butnik-Siverskyi OB. Ekonomika intelektualnoi vlasnosti: konspekt lektsii. Kyiv, 2015. 245. (in Ukrainian)
Keller GN. Guide on Intellectual Property Commercialization. Report prepared for the project on innovation and technology transfer support structure for national institutions (CDIP/3/INF/2). URL: https://dacatalogue.wipo.int/projects/DA_10_03
